FindHealthNews Index  |  Save/Exchange Information |  WikiWax

    News, Reviews, and Articles on Pharmaceutical products

    Archives: Pharmaceutical products

    Drug prices hiked ahead of US health reforms  Nov 23, 2009
    Charles Rangel and Henry Waxman, the chairmen of the House Ways and Means Committee and the House Energy and Commerce Committee respectively, are more skeptical saying that drug manufacturers "may be artificially raising prices for certain pharmaceutical products in expectation of new reforms." Such "price gouging is unacceptable," they said in a letter, "but anticipatory price gouging is especially offensive.". (Agencies). (Xinhuanet, China)

    Circassia Announces Successful Results From Phase II Clinical Study of ToleroMune(R) Cat Allergy Therapy  Nov 20, 2009
    Study Identifies Optimal Treatment Approach for Late-Stage Development. As well as benefiting patients, this effect scientifically validates the ToleroMune approach and its novel focus on generating regulatory T cells to shut down this type of IgE-mediated allergic response. (Canada Newswire)

    Covidien profit plunges, raises outlook  Nov 18, 2009
    Covidien (NYSE: COV), led by Chairman, President and Chief Executive Richard Meelia, operates Covidien Imaging Solutions and Pharmaceutical Products, also known , in St. Louis. Most Read Stories. (St. Louis Business Journal, MO)

    ProMetic Reports Its Third Quarter 2009 Highlights and Financial Results  Nov 14, 2009
    Such risks and assumptions include, but are not limited to, ProMetic's ability to develop, manufacture, and successfully commercialize value-added pharmaceutical products, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of ProMetic to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. You will find... (CCNMatthews Press Releases)

    While mushrooms are easy to spot this time of year, that doesn't mean they are yours for the picking.  Nov 14, 2009
    People need to be open to natural earth medicines rather than pharmaceutical products. (Mushrooms) are the pinnacle example of how the world is balanced and interconnected, Saatdjian said. (Half Moon Bay Review, CA)

    Spherix Incorporated to Webcast Formal Remarks From Annual Meeting of Shareholders  Nov 14, 2009
    The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of Naturlose, the FDA may interpret the results of studies differently than us, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends, our continuing efforts to develop... (Primezone Releases)

    Moves by Ghana to improve access to medicines  Nov 13, 2009
    Dr Addo said most local pharmaceutical industries were collapsing due to the lack of competition and the preferences of foreign pharmaceutical products. He mentioned free zone boundaries, the influx of cheap products from China and India, competitive bidding and manufacturing at large scale for national and international markets as problems facing the industry. (Ghana Web, Ghana)

    CCM plans revamp  Nov 9, 2009
    CCMs diversified business profile encompasses pharmaceutical products, fertilisers and industrial chemicals, enabling it to more effectively withstand a downturn in any particular sector, RAM said in its report. However, CCM remained exposed to the cyclical nature of industrial demand while the performance of its fertilisers division was largely dependent on the fortunes of the palm oil industry, which was also highly cyclical, the rating agency said. (The Star Online, Malaysia -- Business)

    Swine Flu Shot Safety Concerns  Nov 7, 2009
    For pharmaceutical products and vaccines, squalene is extracted from fish oil, and in particular shark liver oil, and then purified. In the article, "Squalene: The Swine Flu Vaccine s Dirty Little Secret Exposed" on the Whale website, Dr. Joseph Mercola describes the ramifications of squalene use in vaccines. (Suite101.com)

    Covidien completes Aspect tender offer  Nov 7, 2009
    Covidien (NYSE: COV) operates Covidien Imaging Solutions and Pharmaceutical Products, also known , in St. Louis. Covidien had nearly $10 billion in revenue in 2008 and has more than 41,000 employees worldwide. (St. Louis Business Journal, MO)

    Hawaii's BBB warns of swine-flu scammers  Nov 3, 2009
    Federal agencies have found contaminated and counterfeit a pharmaceutical products, including Tamiflu, a prescription drug used to treat H1N1 patients, they said. What was sold as the generic version of Tamiflu actually contained vitamin C and other substances that cannot treat nor prevent the H1N1 virus. (Honolulu Star-Bulletin)

    Spammers Target Auto Industry  Nov 1, 2009
    More than 68 percent of the spam identified in the study was related to pharmaceutical products followed by ads for replica products at 18 percent and messages with sexually explicit content checked in at 11 percent. PandaLabs found that banker Trojans were responsible for almost 70 percent of all malware detections followed by adware/spyware and viruses and worms at 22 percent and 8 percent, respectively. (eSecurityPlanet)

    Spammers Target Auto Industry  Nov 1, 2009
    More than 68 percent of the spam identified in the study was related to pharmaceutical products followed by ads for replica products at 18 percent and messages with sexually explicit content checked in at 11 percent. PandaLabs found that banker Trojans were responsible for almost 70 percent of all malware detections followed by adware/spyware and viruses and worms at 22 percent and 8 percent, respectively. (eSecurityPlanet)

    U.S. seeks more clean energy market access in China  Oct 28, 2009
    Locke is pressing China on this visit to crack down on piracy of U.S. intellectual property and to open markets for U.S. medical devices and pharmaceutical products, in addition to energy innovations. On Tuesday, Locke said the United States wants China's currency -- which has been effectively pegged to the dollar since the summer of 2008 -- to climb further. (AlertNet)

    Ascent shares soar on Pfizer deal  Oct 28, 2009
    We will sell and promote their products alongside our extensive range of high quality competitive pharmaceutical products. Our relationship with Pfizer is an excellent fit for both parties. (Sydney Morning Herald -- Business)

    Singapore Output Falls for First Time in Three Months on Lower Drug Sales  Oct 26, 2009
    Singapores recovery has also been boosted by higher output of pharmaceutical products. Electronics Decline. (Bloomberg -- Asia)

    Eisai and TSD Japan Enter into a License and Joint Development Agreement of Denileukin Diftitox in Japan  Oct 26, 2009
    To develop new and innovative pharmaceutical products, TSD has established a unique business model combining expertise in partnering between pharmaceutical companies in Japan and domestic or foreign drug-discovery bio-venture companies, in clinical studies with in-house clinical development functions, and in consulting of clinical development. In January 2009, TSD entered into a license agreement with GenomIdea Inc. to develop, manufacture and distribute HVJ envelope for the treatment of... (JCN Network, Japan)

    ECOWAS gets tough on EU  Oct 20, 2009
    We have much to loose from strained relations with Nigeria as most of our local industries producing such items as pharmaceutical products, furniture, and textiles, aluminum by-products and plastics have the West Africa region as their main market, of which Nigeria constitutes about 60. Ghanas new government had said when it assumed office that it intended to study carefully the text of the Interim EPA initialed by its predecessors before continuing with negotiations. (Ghana Web, Ghana)

    Eisai Opens Regional Office in Bahrain  Oct 16, 2009
    Eisai will commence operations in the region primarily through working with local distributors, while taking responsibility for marketing and registration of pharmaceutical products ... Ltd. Dated Established: June 2009 Location: AL-SEEF, Kingdom of Bahrain Director: Yasushi Okada Scope of Business: Marketing and registration of pharmaceutical products. (JCN Network, Japan)

    OXiGENE to Acquire VaxGen in a Stock-for-Stock Merger  Oct 15, 2009
    Important factors known to OXiGENE and VaxGen that could cause actual results to differ materially from those expressed in such forward-looking statements include general business and economic conditions; the failure of the VaxGen or OXiGENE stockholders to approve the transaction or the failure of either party to meet any of the other conditions to the closing of the transaction; the failure to realize the anticipated benefits from the transaction or delay in realization thereof; OXiGENE's need... (Primezone Releases)

    Nigeria: Death For Fake Drug Merchants? [editorial]  Oct 15, 2009
    What NAFDAC ought to do to curb the stubborn fake drug trade is to step up its monitoring and enforcement duties to ensure the quality of pharmaceutical products in the country ... That is why the NAFDAC boss deserves all the necessary logistics support in his bid to set up control points in China and India - two major pharmaceutical products exporting nations to Nigeria - to verify the quality of drugs headed for Nigeria. (allAfrica.com)

    Novel, soy-based SE5-OH containing Natural S-equol supplement reduced hot flash frequency by nearly 59 percent  Oct 9, 2009
    Otsuka researches, develops, manufactures and markets innovative and original products, with a focus on pharmaceutical products for the treatment of diseases and consumer products for the maintenance of everyday health. Otsuka is committed to being a corporation that creates global value, adhering to the high ethical standards required of a company involved in human health and life, maintaining a dynamic corporate culture, and working in harmony with local communities and the natural... (EurekAlert!)

    Hong Kong Investors Cautious on Wynn Macau IPO  Oct 3, 2009
    While Wynn isn't unique in the same way as Sinopharm, which is the largest distributor of pharmaceutical products in China and the only company of its kind (of significant size) to be listed outside of China, the more modest retail interest is also a clear sign that investors are getting increasingly sceptical about the benefit of participating it IPOs. Many Hong Kong retail investors buy IPOs for the short-term; selling the shares after just a few days for a quick profit. (BusinessWeek)

    Children's Belly Aches Don't Disappear with Antidepressant  Oct 3, 2009
    "Many pharmaceutical products are prescribed for off-label use in children due to the lack of clinical trials testing the efficacy of the drugs in children and adolescents," Saps explained in the news release. "Therefore, the pediatric gastroenterologist frequently has to make treatment decisions without the evidence of how drugs work in children," he added. (MEDLINEplus)

    Covidien device gets FDA approval  Oct 1, 2009
    Covidien operates Covidien Imaging Solutions and Pharmaceutical Products, also known as , in St. Louis. Covidien had nearly $10 billion in revenue in 2008 and has more than 41,000 employees worldwide, including 3,000 in the St. Louis area. (St. Louis Business Journal, MO)

    Antidepressant and placebo are equally effective in child pain relief  Oct 1, 2009
    "Many pharmaceutical products are prescribed for off-label use in children due to the lack of clinical trials testing the efficacy of the drugs in children and adolescents. Therefore, the pediatric gastroenterologist frequently has to make treatment decisions without the evidence of how drugs work in children," said Miguel Saps, MD, of Children's Memorial Hospital and lead author of the study. "The high placebo effect we identified in this study suggests that further studies of the use of... (EurekAlert!)

    Big Pharma Faces a Crackdown in Europe  Oct 1, 2009
    Europeans spend some $275 billion a year on pharmaceutical products an average of $550 for every man, woman and child. But generic medicines can cost as much as 90% less than branded drugs: total savings gained by copycat drugs entry amounted to at least $17 billion over the 2000-2007 period examined by the Commission. (Time.com)

    Perrigo Company (PRGO) Chief Executive Officer to Ring The NASDAQ Stock Market Closing Bell  Sep 26, 2009
    The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico and the United Kingdom. (Primezone Releases)

    Soul Pattinson profit jumps twelve-fold on coal sale  Sep 24, 2009
    "This is a clear result of our diversified investment methodology, focusing on basic commodities such as building products, coal, equities, telecommunications, financial services and pharmaceutical products," he said. The market value of Washington Hs investment portfolio rose 14 per cent to $4 billion by July 31 from $3. (Sydney Morning Herald -- Business)

    U.S. District Court Upholds Validity of Lilly's Evista Patents Through 2014  Sep 24, 2009
    Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind. (PR Newswire)

    Cannabis Science Goes Live with Two National Business Radio Show Interviews Beginning Tomorrow Covering the Nation with Stu Taylor's "Equity Strategies Show"  Sep 23, 2009
    The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance. (Yahoo! Wire -- Entertainment News)

    Fortebio, Inc. to Present at UBS Global Life Sciences Conference  Sep 22, 2009
    Sept. 21 /PRNewswire/ -- ForteBio(R), Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, announced today that Joseph D. Keegan, Ph. D., ForteBio's president and chief executive officer, will present at the UBS Global Life Sciences Conference on Wednesday, September 23, 2009. (PR Newswire)

    Elite Pharmaceuticals Appoints Chief Executive Officer and Chief Scientific Officer  Sep 22, 2009
    Since 2003, Mr. Treppel has served as a member of the board of directors of Akorn, Incorporated (Nasdaq: - ), a specialty pharmaceutical company engaged in the development, manufacturing and marketing of branded and multi-source pharmaceutical products and vaccines. Mr. Treppel serves as the Chair of Akorn's Nominating and Corporate Governance Committee and as a member of its Audit Committee and Compensation Committee. (Primezone Releases)

    Covidien to lay off 70  Sep 22, 2009
    Covidien plc operates and Pharmaceutical Products, also known as , in St. Louis. Covidien was spun off from in 2007. (St. Louis Business Journal, MO)

    Antiques aplenty  Sep 19, 2009
    Anhar, an Indonesian-Chinese lawyer, began his working life as a travelling salesman for pharmaceutical products when he was forced by circumstances to postpone his plans to practise medicine. He did not then envisage giving up on medicine altogether and taking up the legal profession, let alone becoming one of Indonesias most acclaimed hoteliers. (The Star Online, Malaysia)

    My turn: Health care debate picks up pace, shows progress  Sep 19, 2009
    The amazing pharmaceutical products produced by American firms are made possible in part by public dollars underwriting the research and development process. But a far larger incentive for private-sector firms to seek out medicines that produce miraculous results is the economic reward for creating these products. (Juneau Empire)

    Paladin to Present at the UBS Global Life Sciences Conference in New York City  Sep 18, 2009
    Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's leading specialty pharmaceutical companies. (CCNMatthews Press Releases)

    Firms benefit from exports  Sep 15, 2009
    Mineral fuel and oils, soap and waxes, cosmetics, optic and medical instruments and pharmaceutical products industries all saw double-digit increases in export sales last year. Only the auto industry and glass makers posted declining export numbers. (Dayton Business Journal, OH)

    Chicago Bears Quarterback Jay Cutler, Eli Lilly and Company and the American Diabetes Association Team Up to Fund Diabetes Camp Scholarships Through "Touchdowns for Diabetes"  Sep 12, 2009
    Eli Lilly and Company, a leading innovation-driven company, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind. (PR Newswire)

    US recession may be over: Fed survey  Sep 10, 2009
    Several regions noted more production for pharmaceutical products. Although the ailing residential real-estate market is still weak, it also flashed signs of improvements. (India Times)

    Hana Biosciences Receives NASDAQ Delisting Notification  Sep 9, 2009
    Additional risks that may affect such forward-looking statements include Hana's need to raise additional capital to fund its product development programs to completion, Hana's reliance on third-party researchers to develop its product candidates, and its lack of experience in developing and commercializing pharmaceutical products. Additional risks are described in the company's Annual Report on Form 10-K for the year ended December 31, 2008 filed with the Securities and Exchange Commission. (Primezone Releases)

    REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder  Sep 8, 2009
    Text hiding to spacing. LONDON, September 7 /PRNewswire/ -- Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7). (PR Newswire)

    Sigma pushes for $297m, announces $60m buy-up  Sep 7, 2009
    Sigma and BMS will also enter into a manufacturing agreement for a period of up to five years, under which Sigma will manufacture certain pharmaceutical products for BMS for distribution overseas. Sigma said the acquired brand portfolio and manufacturing contracts currently generate annual turnover of about $50 million, comprising $33 million from acquired brands and $17 million from contract manufacturing. (Sydney Morning Herald -- Business)

    Loyalty is enough  Sep 6, 2009
    HOUSEHOLD brand Hai-O is known for its traditional herbal and pharmaceutical products, some of which are quite bitter ... Chinese herbal and pharmaceutical products will always remain Hai-Os core business, said Tan, who also founded the Malaysia-China Friendship Association. (The Star Online, Malaysia)

    Anticancer compound found in American mayapple  Sep 6, 2009
    Podophyllotoxin and its derivatives are used in several commercially available pharmaceutical products such as the anticancer drugs etoposide, teniposide, and etopophos, which are used in the treatment of small-cell lung cancer, lymphoblastic leukemia, testicular cancer, and brain tumors. Podophyllotixin derivatives are also used for the treatment of psoriasis and malaria, and some are being tested for the treatment of rheumatoid arthritis. (EurekAlert!)

    KV Pharmaceutical Appoints Interim Chief Financial Officer  Sep 5, 2009
    KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets, and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products ... Such factors include (but are not limited to) the following: (1) the ability to continue as a going concern; (2) changes in the current and future business environment, including interest rates and capital and consumer spending; (3) the difficulty of predicting FDA... (PR Newswire)

    Food and Drugs Authorities to ensure quality control  Sep 5, 2009
    He explained that pharmaceutical products constituted about 30 to 36 per cent of all health budget expenditure in many developing countries and governments placed high premium on policies that would ensure the availability and access to medicines at affordable prices. He complained of the numerous tragedies associated with medicines notwithstanding their benefits which he said had resulted from the use of medicines contaminated with toxic ingredients, impurities of degradation, substandard and... (Ghana Web, Ghana)

    Saxena White P.A. Reminds All Matrixx Initiatives, Inc. Investors of September 15, 2009 Lead Plaintiff Deadline -- MTXX  Sep 5, 2009
    The Company, through its subsidiary, produces, markets and sells, among other pharmaceutical products, Zicam Cold Remedy nasal gel, Zicam Cold Remedy gel swabs, and Zicam Cold Remedy children's swabs. The Complaint alleges that, throughout the Class Period, Defendants failed to disclose material adverse facts concerning the Company's operational well-being and future prospects. (Primezone Releases)

    Sinopharm targets US$1bil from IPO  Sep 5, 2009
    HONG KONG: China s largest pharmaceutical products distributor, Sinopharm Group Co Ltd, is set to raise up to HK$8. 73bil (US$1. (The Star Online, Malaysia -- Business)

    Sinopharm Said to Seek Up to $1.13 Billion in Hong Kong Initial Share Sale  Sep 4, 2009
    The nations only central government-controlled drug seller is raising capital to expand, improve its distribution and retail networks, buy foreign pharmaceutical products, upgrade its logistics systems and better its information technology and e- commerce platform, according to a preliminary share sale document sent to investors Aug. 31. Chinas pharmaceutical market is expected to grow 17 percent annually in the next five years, on the back of an aging population, rising household income,... (Bloomberg -- Asia)

    Virginia to benefit from largest heath care fraud settlement in U.S. history  Sep 4, 2009
    3 billion nationally to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products. Virginia's total federal and state Medicaid recovery is nearly 12 million, with 6. (Chatham Star Tribune, VA)

    Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009  Sep 1, 2009
    The company markets its branded pharmaceutical products to physicians in pain management, neurology, surgery, oncology, endocrinology and primary care. More information, including this and past press releases of Endo Pharmaceuticals, is available at. (PR Newswire)

    Hisamitsu completes Noven acquisition  Aug 30, 2009
    Hisamitsu Pharmaceutical Co. develops and markets prescription and over-the-counter pharmaceutical products using transdermal delivery systems technology. Noven, which also manufactures transdermal patches that deliver drugs through the skin, joins a long list of local pharmaceutical and medical device companies that have been bought out. (South Florida Business Journal, FL)

    Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations  Aug 28, 2009
    These statements involve a number of risks and uncertainties, including the difficulty of predicting FDA approvals, the acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, the timely development and launch of new products, and the risk factors listed from time to time in Forest Laboratories' Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and any subsequent SEC filings. For further information Nycomed Media: General phone: +1 917 968... (PR Newswire)

    Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin, An Investigational Treatment for Type 2 Diabetes  Aug 28, 2009
    As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products ... Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. (PR Newswire)

    Hisamitsu Pharmaceutical Completes Acquisition of Noven Pharmaceuticals  Aug 28, 2009
    Hisamitsu Pharmaceutical Co., Inc. is a leading pharmaceutical company that develops and markets prescription and over-the-counter ("OTC") pharmaceutical products using transdermal delivery systems technology ... Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. (PR Newswire)

    China Sky One Medical, Inc. Responds to Concerns Regarding Filed Financial Reports  Aug 27, 2009
    Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit. (PR Newswire)

    Transcept Pharmaceuticals to Present at Rodman & Renshaw and Baird Healthcare Investor Conferences on September 9 and September 10, 2009  Aug 27, 2009
    October 30, 2009 is the PDUFA target date for the FDA to take action on its review of the Intermezzo(R) NDA. Transcept and Purdue Pharmaceutical Products, L.P. have entered into a collaboration agreement for the development and commercialization of Intermezzo(R) in the United States. For further information, please visit the company's website at. (PR Newswire)

    Irish drug group to buy P&G unit for $3.1 bln  Aug 25, 2009
    Warner Chilcott will acquire P&G's portfolio of pharmaceutical products plus 2,300 employees working for the division. "The acquisition of the P&G pharmaceutical brands and employee talent is a transformational, strategic move for us," said Roger Boissonneault, president and chief executive officer of Warner Chilcott. (Yahoo News -- Pharmaceutical Industry News)

    Green goo gets a boost  Aug 24, 2009
    These include things that consumers are hardly aware of but that can be higher-value products, like excipients used in pharmaceutical products: Seambiotic make food additives in addition to biofuels; Solazyme has made nutraceuticals, additives and soaps using algae. "The possibilities are endless," says Udupa. (CNN -- International)

    Roadside clinics to cater to truck drivers  Aug 22, 2009
    In addition, the clinics will market their own line of nutritional and pharmaceutical products and healthy to-go meals to give truckers the best opportunity to have a healthier lifestyle like anyone else does, Perry said. The Dallas and Fort Worth clinics will be two of six locations that Roadside plans to build in Texas, Perry said. (Dallas Business Journal, TX)

    Tewksbury business acquired by Horn Packaging  Aug 14, 2009
    New England is known for its high tech products and precise medical devices as well as electronic and industrial machinery, pharmaceutical products, vehicle parts and US defense equipment. Horn s ability to take care of such delicate and very expensive cargo has won it recognition around the world. (Tewksbury Advocate, MA)

    Update on Astellas' Request for Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications  Aug 13, 2009
    Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. (PR Newswire)

    Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Imitrex(R) Tablets  Aug 12, 2009
    These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission, including Part I, Item 1A of our most recent Form 10-K, and include but are not limited to: information of a preliminary nature that may be subject to adjustment, potentially not obtaining or delay in obtaining FDA approval for new products, governmental restrictions on the sale of certain products, development by competitors of new or superior products or less expensive products... (PR Newswire)

    McKinney global spam ringleader pleads guilty  Aug 12, 2009
    The complaint said Smith is liable for allegedly making false claims about pharmaceutical products and Atkinson is liable for alleged false statements about all of the messages claims, according to the FTC.. FTC officials also claim the companies processed more than 400,000 in Visa charges for these products, according to the New York Times. (McKinney Courier-Gazette, TX)

    3SBio Inc. Announces Unaudited Second Quarter 2009 Results  Aug 12, 2009
    SHENYANG, China, Aug. 11 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: ) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the second quarter ended June 30, 2009 ... 3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products,... (PR Newswire)

    Harriman campus to be home to $40M state food lab  Aug 8, 2009
    The lab has cooperative agreements with the U.S. Department of Agriculture (USDA) for the Microbiological Data Program to detect pathogens in fresh food and the Pesticide Data Program to test fruit, vegetables, and public drinking water for pesticide residues and drinking water for a variety of pharmaceutical products. Last year, about 140,000 analyses on more than 19,000 samples of food, beverage, animal feed, fertilizer and lime samples were performed at the New York State Food Lab as part of... (Albany Business Review, NY)

    Duane Reade Holdings, Inc. Announces Closing of Offering of $300 Million of 11.75% Senior Secured Notes Due 2015  Aug 8, 2009
    Those risks include, among other things, the national economic climate, economic conditions and employment levels in the New York greater metropolitan area, the strength of the economy in general, the competitive environment in the drug store industry in general and in the New York metropolitan area, the ability to open and operate new stores, the continued efforts by payers and government agencies to reduce prescription reimbursement rates and prescription drug benefits, changes in federal and... (PR Newswire)

    Covidien receives FDA clearance for its Puritan Bennett 840 ventilator system  Aug 7, 2009
    Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. (EurekAlert! -- Business News)

    ProMetic Reports its Second Quarter 2009 Highlights and Financial Results  Aug 6, 2009
    Such risks and assumptions include, but are not limited to, ProMetic's ability to develop, manufacture, and successfully commercialize value-added pharmaceutical products, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of ProMetic to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. You will find... (CCNMatthews Press Releases)

    FDA extends review of Coviden drug  Aug 5, 2009
    Covidien plc, formerly known as , operates Covidien Imaging Solutions and Pharmaceutical Products, also known as Mallinckrodt Inc., which is located in St. Louis and provides medical imaging technology and pharmaceuticals. Covidien was spun off from in 2007. (St. Louis Business Journal, MO)

    Trade mission to Australia gets RM372m proposed investments  Aug 5, 2009
    International Trade and Industry Minister Datuk Mustapa Mohamed said the proposed investments comprised pharmaceutical products, refurbishment of mobile phones, aerospace and maintenance, repair and overhaul activities, chemical products, waste water treatment, waste metal recycling, and machinery. The mission also managed to secure RM130mil sales under negotiations to Australia in areas like trade, manufacturing and services, he told Bernama here yesterday. (The Star Online, Malaysia -- Business)

    FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia  Aug 4, 2009
    A privately held company, KPA focuses its efforts on the acquisition, development, licensing and marketing of pharmaceutical products. Its lead product, LIPOFEN(R) (fenofibrate capsules), is indicated as adjunctive therapy to diet to reduce elevated triglycerides and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia. (PR Newswire)

    Transcept rises on Purdue sleep aid license  Aug 4, 2009
    NEW YORK Shares of Transcept Pharmaceuticals Inc. rocketed Monday after the company said it licensed its insomnia treatment candidate Intermezzo to Purdue Pharmaceutical Products LP for up to $145 million, plus royalty payments. The agreement gives Purdue the exclusive right to sell the drug in the U.S. and negotiate for its approval in Canada and Mexico. (Yahoo News -- Pharmaceutical Industry News)

    Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)  Aug 3, 2009
    Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and marketing pharmaceutical products that target unmet medical needs in both niche and broader specialty markets. Savient has developed one product: KRYSTEXXA(TM) (pegloticase) which is a PEGylated uricase enzyme intended for the treatment of chronic gout in patients refractory to conventional therapy. (PR Newswire)

    Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States  Aug 3, 2009
    Aug. 2 /PRNewswire-FirstCall/ -- Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. (Nasdaq: ) today announced entry into an exclusive license and collaboration agreement to commercialize Intermezzo((R)) (zolpidem tartrate sublingual tablet) in the United States ... SOURCE Transcept Pharmaceuticals, Inc.; Purdue Pharmaceutical Products L.P.. (PR Newswire)

    Preferred Freezer Services Breaks Ground in Shanghai in First US-China Cold Storage Development  Jul 30, 2009
    China has the world's fastest-growing consumer market for perishable food and pharmaceutical products, but its per capita refrigerated warehouse space is less than one-tenth of most developed countries. The demand for cold chain facilities with improved quality is enormous in China and with the growth of foreign capital in recent years; this presents investors with massive opportunities. (PR Newswire)

    Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe  Jul 29, 2009
    The centralized review process provides for a single coordinated review for approval of pharmaceutical products that is conducted by the EMEA on behalf of all European Union ("EU") member states. The EMEA also designated pixantrone as a New Active Substance ("NAS"); if approved, compounds designated as an NAS receive a 10-year market exclusivity period in EU member states. (PR Newswire)

    Grupo Casa Saba Announces Quarterly Earnings Report 2Q09  Jul 28, 2009
    MEXICO CITY, July 27 /PRNewswire-FirstCall/ -- Grupo Casa Saba (NYSE: ) ("Saba", "GCS", "the Company" or "the Group"), one of the leading Mexican distributors of pharmaceutical products, health and beauty aids, personal care and consumer goods, general merchandise, publications and other products, announces its consolidated financial and operating results for the second quarter of 2009. Financial Highlights. (PR Newswire)

    Labs at centre of outbreak  Jul 28, 2009
    Merial also produces a range of other pharmaceutical products for livestock, pets and wildlife. Last year, sales of its products topped 2. (BBC News -- Science)

    Anesiva Receives NASDAQ Delisting Staff Determination Letter  Jul 24, 2009
    Anesiva seeks to be a leader in the development and commercialization of novel pharmaceutical products for pain management. The company's lead product candidate is Adlea, a novel small molecule formulation of capsaicin that is currently in development for the management of acute pain following orthopedic surgeries. (PR Newswire)

    Publicis Groupe Services: Half-Year 2009 Results  Jul 23, 2009
    mobil Vodafone (Slovenia), Jenny Craig (United States), Ubank (Australia), Jamena Gas Networks (Australia), China Mobile (China), T38/40 weight-loss product (Portugal), MTV (United Kingdom), Panasonic (Indonesia), Turismo de Valencia (Spain), Haberturk newspaper (Turkey), BA airline company (Digital) (United Kingdom), Kang Yuan pharmaceutical products (China), Parques Reunidos amusement parks (Spain), sanofi-aventis (Ukraine), Madrid 2016 (Spain), ICO public institute for loans and financing... (PR Newswire)

    3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009  Jul 23, 2009
    SHENYANG, China, July 23 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: ), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release financial results for the second quarter ended June 30, 2009 after the US market closes on Tuesday, August 11, 2009 ... 3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing... (PR Newswire)

    Nigeria: Menace of Substandard Drugs [editorial]  Jul 21, 2009
    Abuja The Pharmaceutical Council of Nigeria (PCN) recently alerted the nation to the increasing rate of fake pharmaceutical products in circulation, and attributed the trend to the failure of manufacturers to conform to standards. The Registrar/Chief Executive Officer of the Council, Pharmacist Ahmed Mora, who spoke at a workshop for South-west pharmacists in Lagos recently said reports collated by PCN inspectors who conducted routine inspections of drug companies nationwide indicated that... (allAfrica.com)

    UEM Land, BiotechCorp to form SPV next month  Jul 21, 2009
    Malaysia is also rich in biodiversity, especially our plant species in the centuries-old jungles, that can be developed into pharmaceutical products through Riatives and activities, said Zulkifli. LATEST STORIES. (The Star Online, Malaysia)

    Archives: Pharmaceutical products

    Back to FindHealthNews Home

[ Terms Of Use | Privacy | About ]
©1998-2006 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2006